Solid-phase synthesis of 1,2,3,4-tetrahydro-β-carboline-containing peptidomimetics

Organic Letters

Volumn 2, Issue 20, 2000, Pages 3075-3078

  Li, Xianfeng ^a,b   Zhang, Lianshan ^a   Zhang, Wei ^a   Hall, Steven E ^a   Tam, James P ^b  

^a ELI LILLY AND COMPANY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOLINE DERIVATIVE; PEPTIDE; TRYPTOLINE; TRYPTOPHAN;

ARTICLE; CHEMISTRY; SYNTHESIS;

CARBOLINES; PEPTIDES; TRYPTOPHAN;

EID: 0034609697     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol006209z     Document Type: Article

References (48)

1. For recent reviews in solid-phase organic synthesis, see: (a) Lorsbach, B. A.; Kurth, M. J. Chem. Rev. 1999, 99, 1549-1581.
2. (b) Hall, S. E. Mol. Diversity 1999, 4, 131-142.
3. (c) Gordon, E. M.; Gallop, M. A.; Patel, D. V. Acc. Chem. Res. 1996, 29, 144-154.
4. (d) Fruechtel, J. S.; Jung, G. Angew. Chem., Int. Ed. Engl. 1996, 35, 17-42.
5. For recent reviews in combinatorial chemistry, see: (a) Dolle, R. E.; Nelson, K. H. J. Comb. Chem. 1999, 1, 235-282.
6. (b) Hall, S. E. Comb. Chem. Mol. Diversity Drug Discovery 1998, 291-306.
7. (c) Lam, K. S.; Krchnak, V. Chem. Rev. 1997, 97, 411-448.
8. (d) Armstrong, R. W.; Combs, A. P.; Tempest, P. A.; Brown, S. D.; Keating, T. A. Acc. Chem. Res. 1996, 29, 123-131.
9. (e) Nefzi, A.; Ostresh, J. M.; Houghten, R. A. Chem. Rev. 1997, 97, 449-472.
10. (f) Thompson, L. A.; Ellman, J. A. Chem. Rev. 1996 96, 555-600.
11. Merrifield, R. B. J. Am. Chem. Soc. 1963, 85, 2149-2154.
12. (a) Hirschmann, R.; Nicolaou, K. C.; Pietranico, S.; Salvino, J.; Leahy, E. M.; Sprengeler, P. A.; Furst, G.; Smith, A. B. J. Am. Chem. Soc. 1992, 114, 9217-9218.
13. (b) Hirschmann, R.; Sprengeler, P. A.; Kawasaki, T.; Leahy, J. W.; Shakespeare, W. C.; Smith, A. B. J. Am. Chem. Soc. 1992, 114, 9699-9701.
14. (c) Wiley, R. A.; Rich, D. H. Med. Res. Rev. 1993, 13, 327-384.
15. (d) Janetka, J. W.; Rich, D. H. J. Am. Chem. Soc. 1995, 117, 10585-10586.
16. (a) Creighton, C. J.; Zapf, C. W.; Bu, J. H.; Goodman, M. Org. Lett. 1999, 1, 1407-1409.
17. (b) McComsey, D. F.; Hawkins, M. J.; Andrade-Gordon, P.; Addo, M. F.; Oksenberg, D.; Maryanoff, B. E. Bioorg. Med. Chem. Lett. 1999, 9, 1423-1428.
18. (c) Asche, G.; Kunz, H.; Nar, H.; Koppen, H.; Briem, H.; Pook, K.-H.; Schiller, P. W.; Chung, N. N.; Lemieux, C.; Esser, F. J. Pept. Res. 1998, 51, 323-336.
19. (d) Li, Y.-M; Milne, J. C.; Madison, L. L.; Kolter, R.; Walsh, C. T. Science, 1996, 274, 1188-1193.
20. Hanessian, S.; Mcnaughton-Smith, G.; Lombart, H.-G.; Lubell, W. D. Tetrahedron 1997, 53, 12789-12854.
21. (a) Souers, A. J.; Virgilio, A. A.; Rosenquist, S. A.; Fenuik, W.; Ellman, J. A. J. Am. Chem. Soc. 1999, 121, 1875-1825.
22. (b) Boteju, L. W.; Nikiforovich, G. V.; Haskell-Luevano, C.; Fang, S. N.; Zalewska, T.; Stropova, D.; Yamamura, H. I.; Hruby, V. J. J. Med. Chem. 1996, 39, 4120-4124
23. (c) Haskell-Luevano, C.; Toth, K.; Boteju, L.; Job, C.; de Castrucci, A. M.; Hadley, M. E.; Hruby, V. J. J. Med. Chem. 1997, 40, 2740-2749.
24. (d) Nargund, R. P.; Chen, M.-H.; Johnston, D. B. R.; Barakat, K. J.; Tata, J. R.; Cheng, K.; Jacks, T. M.; Chan, W. W.-S.; Wei, L.; Butler, B. R.; Hickey, G. J.; Smith, R. G.; Patchett, A. A. Bioorg. Med. Chem. Lett. 1996, 6, 1731-1736.
25. Cox, E. D.; Cook, J. M. Chem. Rev. 1995, 95, 1797-1842.
26. Audia, J. E.; Evrard, D. A.; Murdoch, G. R.; Droste, J. J.; Nissen, J. S.; Schenck, K. W.; Fludzinski, P.; Lucaites, V. L.; Nelson, D. L.; Cohen, M. L. J. Med. Chem. 1996, 39, 2773-2780.
27. Pictet, A.; Spengler, T. Chem. Ber. 1911, 44, 2030-2036.
28. For solid-phase Pictet-Spengler reaction, see: (a) Mayer, J. P.; Bankaitis-Davis, D.; Zhang, J.; Beaton, G.; Bjergarde, K.; Andersen, C. M.; Goodman, B. A.; Herra, C. J. Tetrahedron Lett. 1996, 37, 5633-5636.
29. (b) Kaljuste, K.; Unden, A. Tetrahedron Lett. 1995, 36, 9211-9214.
30. (c) Mohan, R.; Chou, Y.-L.; Morrissey, M. M. Tetrahedron Lett. 1996, 37, 3963-3966.
31. (d) Yang, L.; Guo, L. Tetrahedron Lett. 1996, 37, 5041-5044.
32. (e) Fantauzzi, P. P.; Yager, K. M. Tetrahedron Lett. 1998, 39, 1291-1294.
33. (f) van Loevezijn, A.; van Maarseveen, J. H.; Stegman, K.; Visser, G. M.; Koomen, G.-J. Tetrahedron Lett. 1998, 39, 4737-4740.
34. (g) Wang, H.; Ganesan, A. Org. Lett. 1999, 1, 1647-1649.
35. (a) Li, X.; Zhang, L.; Hall, S. E.; Tam, J. P. Tetrahedron Lett. 2000, 41, 4069-4073.
36. (b) Tam, J. P.; Rao, C.; Liu, C. F.; Shao, J. Int. J. Pept. Protein Res. 1995, 45, 209-216.
37. Wang, S. S. J. Am. Chem. Soc. 1973, 95, 1328-1333.
38. Barany, G.; Merrifield, R. B. In The Peptide; Gross, E., Meienhofer, J., Eds.; Academic Press: New York, 1979; Vol. 2, p 1.
39. 2 according to the following: Liu, C.-F.; Tam, J. P. Proc Natl. Acad. Sci. U.S.A. 1994, 91, 6584-6588.
40. 2 (3 × 2 mL). If the ninhydrin test showed a positive result, then the procedure was repeated. The resin was used directly for the next step of the reaction. Final products were cleaved from the resin with TFA/water (95:5).
41. Sarin, V. K.; Kent, S. B. H.; Tam, J. P.; Merrifield, R. B. Anal. Biochem. 1981, 117, 147-157.
42. 2O). Gradient: 10% to 100% B within 15 min. UV monitoring at 220 nm.
43. LC-MS was performed on a Hewlett-Packard 1100 system.
44. 6, 300 MHz), δ 11.1, 11.2 (s, 1H), 7.0-7.6 (m, 4H), 4.7-4.9 (m, 1H), 4.1-4.3 (m, 1H), 3.2-3.4 (m, 2H), 2.9-3.2 (m, 2H).
45. 1H NMR analysis of the THBC core 7j indicated that the diastereomeric ratio is approximately 1:1 in the mixture.
46. (a) Douat, C.; Heitz, A.; Martinez, J.; Fehrentz, J.-A. Tetrahedron Lett. 2000, 41, 37-40.
47. (b) Wen, J. J.; Crews, C. M. Tetrahedron: Asymmetry 1998, 9, 1855-1858.
48. (c) Myers, A. G.; Zhong, B.; Movassaghi, M.; Kung, D. W.; Lanman, B. A.; Kwon, S. Tetrahedron Lett. 2000, 41, 1359-1362.